INVENTIVA (EPA:IVA) | Finanzwire

Basculer en Français

8301	Companies
115073	Keywords
55420	Articles
62512	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 07/18/2024 at 08:30, 4 months 3 days ago

Inventiva announces a €20.1 million issuance of royalty certificates
Inventiva announces a €20.1 million issuance of royalty certificates to fund lanifibranor development, extending cash runway. Key shareholders involved in the transaction

Strategic Options Inventiva Lanifibranor Royalty Certificates Cash Runway
BRIEF

published on 07/05/2024 at 22:05, 4 months 15 days ago

Inventiva: update on the NATiV3 clinical program and financial statement

Funding Clinical Test Inventive NASH Lanifibranor
PRESS RELEASE

published on 07/05/2024 at 22:00, 4 months 15 days ago

Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position
Inventiva updates on its clinical program evaluating lanifibranor for MASH/NASH, with positive recruitment and financial outlook. New patents strengthen the company's position

Financial Position Clinical Program Inventiva Lanifibranor MASH/NASH
PRESS RELEASE

published on 06/21/2024 at 22:05, 4 months 29 days ago

Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024
Description of the share repurchase program authorized by the Ordinary General Meeting of 20 June 2024 by Inventiva SA. Details on objectives, maximum capital proportion, and allocation of treasury shares presented

Liquidity Agreement Ordinary General Meeting AMF General Regulations Share Repurchase Program Inventiva SA
BRIEF

published on 06/21/2024 at 22:05, 4 months 29 days ago

Results of the Combined Shareholders' General Meeting of June 20, 2024

Shareholders' Meeting Resolutions Votes Inventiva
PRESS RELEASE

published on 06/21/2024 at 22:00, 4 months 29 days ago

Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024
Inventiva announces voting results of Combined Shareholders' Meeting held on June 20, 2024. All resolutions, except 30th, were adopted. Details of votes and quorum provided

Voting Results Quorum Combined Shareholders' Meeting Resolutions Adopted Inventiva
BRIEF

published on 05/30/2024 at 08:35, 5 months 22 days ago

Inventiva Combined General Meeting of June 20, 2024 - Conditions for making preparatory documents available

Shareholders Biopharmaceutical General Assembly Preparatory Documents Inventive
BRIEF

published on 05/30/2024 at 08:35, 5 months 22 days ago

Inventiva: Status of voting rights and shares as of May 13, 2024

Euronext Paris Share Capital Voting Rights Financial Transparency Inventive
BRIEF

published on 05/27/2024 at 09:12, 5 months 25 days ago

Crossing threshold for INVENTIVA

Capital Transfer Of Shares Crossing Threshold Inventiva UBS Group AG
BRIEF

published on 05/21/2024 at 22:05, 5 months 30 days ago

Inventiva Releases First Quarter 2024 Financial Results and Business Updates

Financial Results Treasury BEI Inventive NATiV3 Clinical Trials

Accesswire

Published on 11/21/2024 at 17:35, 59 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 1 hour 4 minutes ago

SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 2 hours 4 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 2 hours 33 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 2 hours 34 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 17:58, 35 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 42 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 42 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 16:00, 2 hours 33 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 2 hours 52 minutes ago

Edison issues report on Murray Income Trust (MUT)

Les Echos

Published on 11/21/2024 at 06:58, 11 hours 36 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 23 hours 14 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 10 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE